Cortisol/DHEA ratio and the rates of blood serum lipid profile in patients with diabetes mellitus type 2 with different visceral adiposity index

Authors

  • Наталія Миколаївна Кушнарьова State institution “V. P. Komissarenko Institute of Endocrinology and Metabolism of the National Academy of Medical Science” 69 Vyshgorodskaya str., Kyiv, Ukraine, 04114, Ukraine
  • Вадим Валерійович Корпачев State institution “V. P. Komissarenko Institute of Endocrinology and Metabolism of the National Academy of Medical Science” 69 Vyshgorodskaya str., Kyiv, Ukraine, 04114, Ukraine
  • Олеся Вадимівна Корпачева-Зінич State institution “V. P. Komissarenko Institute of Endocrinology and Metabolism of the National Academy of Medical Science” 69 Vyshgorodskaya str., Kyiv, Ukraine, 04114, Ukraine
  • Наталія Марківна Гуріна State institution “V. P. Komissarenko Institute of Endocrinology and Metabolism of the National Academy of Medical Science” 69 Vyshgorodskaya str., Kyiv, Ukraine, 04114, Ukraine
  • Ольга Володимирівна Прибила State institution “V. P. Komissarenko Institute of Endocrinology and Metabolism of the National Academy of Medical Science” 69 Vyshgorodskaya str., Kyiv, Ukraine, 04114, Ukraine

DOI:

https://doi.org/10.15587/2313-8416.2016.59277

Keywords:

visceral adiposity index, diabetes mellitus type 2, lipid spectrum, cortisol, DHEA

Abstract

Aim of the work. To determine the possibility of using visceral adiposity index (VAI) for diagnostics of the lipid metabolism disorders and corticosteroid balance in patients with diabetes mellitus type 2 (DM2).

Methods. In 19 patients with diabetes mellitus type 2older than 50 years old were detected body mass, height, waist size, blood serum lipid spectrum (triglycerides LPHD), were calculated body mass index (BMI), VAI, cortisol/ dehydroeipandrosterone (DHEA) ratio.

Results. The examined patients were divided into 3 groups (tertiles) on VAI rate. An increase of VAI tertile was attended by the changes of blood serum lipid spectrum (increase of TG levels and decrease of LPHD, increase of LPVLD). The changes of lipid rates in I-III tertiles on VAI level did not depend on BMI rates and waist size (WS) as indicators of the general and abdominal adiposity respectively, on the contrary in III group there was fixed an increase of hypodermic adipose plica. There was not revealed an increase of C-peptide concentration (insulin secretion characteristics). An increase of VAI value in patients with DM2 was also attended with unfavorable quantitative changes of corticosteroid concentration namely an increase of cortisol level and decrease of DHEA-C (DHEA-sulfate) level. In groups of patients with low and high VAI there was revealed the different character of correlative interconnection between VAI value and cortisol, DHEA-C levels, cortisol/DHEA ratio that is: the direct (physiological) correlation detected in the conditions of the low VAI was changed into an opposite one in patients with the high VAI that demonstrated the disturbance of the balance between cortisol and DHEA that must to counterpoise one another in the normal conditions.

Conclusion. VAI is the more sensitive indicator for assessment of the general and abdominal adiposity parameters and the lipid spectrum rates comparing with BMI and WS. VAI value demonstrated an interconnection with disturbance of cortisol/DHEA ratio and LPVLD levels that indicates the possibility of using VAI and cortisol/DHEA coefficients for assessment of the disturbance of lipid balance and corticosteroid balance in patients with DM2

Author Biographies

Наталія Миколаївна Кушнарьова, State institution “V. P. Komissarenko Institute of Endocrinology and Metabolism of the National Academy of Medical Science” 69 Vyshgorodskaya str., Kyiv, Ukraine, 04114

Senior Researcher

Department of clinical pharmacology and aging endocrinology

Вадим Валерійович Корпачев, State institution “V. P. Komissarenko Institute of Endocrinology and Metabolism of the National Academy of Medical Science” 69 Vyshgorodskaya str., Kyiv, Ukraine, 04114

Heard of department

PhD, Doctor of Medical Sciences, Professor

Dep. of clinical pharmacology and pharmacotherapy of endocrine diseases

Олеся Вадимівна Корпачева-Зінич, State institution “V. P. Komissarenko Institute of Endocrinology and Metabolism of the National Academy of Medical Science” 69 Vyshgorodskaya str., Kyiv, Ukraine, 04114

PhD, Doctor of Medical Sciences

Senior Research Fellow

Dep. of clinical pharmacology and aging endocrinology

Наталія Марківна Гуріна, State institution “V. P. Komissarenko Institute of Endocrinology and Metabolism of the National Academy of Medical Science” 69 Vyshgorodskaya str., Kyiv, Ukraine, 04114

PhD

Lead Research Fellow

Dep. of clinical pharmacology and pharmacotherapy of endocrine diseases

Ольга Володимирівна Прибила, State institution “V. P. Komissarenko Institute of Endocrinology and Metabolism of the National Academy of Medical Science” 69 Vyshgorodskaya str., Kyiv, Ukraine, 04114

Junior Research Fellow

Dep. of clinical pharmacology and aging endocrinology

References

Geetha, L., Deepa, M., Anjana, R. M., Mohan, V. (2011). Prevalence and Clinical Profile of Metabolic Obesity and Phenotypic Obesity in Asian Indians. Journal of Diabetes Science and Technology, 5 (2), 439–446. doi: 10.1177/193229681100500235

Tytov, V. N. (2009). Ateroscleros – problema obsey biologii: narusheie bioligicheskih funkciy pitaniya I endoecologii [Atherosclerosis – a common problem of biology: violation of biological functions of supply and Endoecology]. Successes of modern biology, 129 (2), 124–143.

Tytov, V. N. (2013). Statiny, holesterin, zyrnie kisloty I saharniy diabet [Satins, cholesterol, fatty acids and diabetes mellitus]. Nauchniy dialog, 3 (15), 148–183.

Aronson, D. (2009). Cortisol – Its Role in Stress, Inflammation, and Indications for Diet Therapy. Today’s Dietetian, 11 (11), 38.

Jablonka, E., Raz, G. (2009). Transgenerational Epigenetic Inheritance: Prevalence, Mechanisms, and Implications for the Study of Heredity and Evolution. The Quarterly Review of Biology, 84 (2), 131–176. doi: 10.1086/598822

Korpachev, V., Korpacheva-Zynych, O. (2011). Evoluciya vsgladov v diabetologii [The evolution of views in Diabetology]. Кyiv: Kniga-plus, 224.

Bauer, M. E., Jeckel, C. M. M., Bonorino, C., Ribeiro, F., Luz, C. (2009). Glucocorticoids and DHEA: Do they have a role in immunosenescence? Springer Science, 833–862. doi: 10.1007/978-1-4020-9063-9_43

Hughes, K. A., Manolopoulos, K. N., Iqbal, J., Cruden, N. L., Stimson, R. H., Reynolds, R. M. et. al (2012). Recycling Between Cortisol and Cortisone in Human Splanchnic, Subcutaneous Adipose, and Skeletal Muscle Tissues In Vivo. Diabetes, 61 (6), 1357–1364. doi: 10.2337/db11-1345

Gross, K. L., Cidlowski, J. A. (2008). Tissue-specific glucocorticoid action: a family affair. Trends in Endocrinology & Metabolism, 19 (9), 331–339. doi: 10.1016/j.tem.2008.07.009

Buford, T. W., Willoughby, D. S. (2008). Impact of DHEA(S) and cortisol on immune function in aging: a brief review. Applied Physiology, Nutrition, and Metabolism, 33 (3), 429–433. doi: 10.1139/h08-013

Phillips, A. C., Carroll, D., Gale, C. R., Lord, J. M., Arlt, W., Batty, G. D. (2010). Cortisol, DHEA sulphate, their ratio, and all-cause and cause-specific mortality in the Vietnam Experience Study. European Journal of Endocrinology, 163 (2), 285–292. doi: 10.1530/eje-10-0299

McNelis, J. C., Manolopoulos, K. N., Gathercole, L. L., Bujalska, I. J., Stewart, P. M., Tomlinson, J. W., Arlt, W. (2013). Dehydroepiandrosterone exerts antiglucocorticoid action on human preadipocyte proliferation, differentiation, and glucose uptake. AJP: Endocrinology and Metabolism, 305 (9), E1134–E1144. doi: 10.1152/ajpendo.00314.2012

Ohlsson, C., Labrie, F., Barrett-Connor, E., Karlsson, M. K., Ljunggren, Ö., Vandenput, L. et. al (2010). Low Serum Levels of Dehydroepiandrosterone Sulfate Predict All-Cause and Cardiovascular Mortality in Elderly Swedish Men. The Journal of Clinical Endocrinology & Metabolism, 95 (9), 4406–4414. doi: 10.1210/jc.2010-0760

Davis, S. R., Shah, S. M., McKenzie, D. P., Kulkarni, J., Davison, S. L., Bell, R. J. (2008). Dehydroepiandrosterone Sulfate Levels Are Associated with More Favorable Cognitive Function in Women. The Journal of Clinical Endocrinology & Metabolism, 93 (3), 801–808. doi: 10.1210/jc.2007-2128

Amato, M. C., Giordano, C., Galia, M., Criscimanna, A., Vitabile, S., Midiri, M., Galluzzo, A. (2010). Visceral Adiposity Index: A reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care, 33 (4), 920–922. doi: 10.2337/dc09-1825

Petta, S., Amato, M., Cabibi, D., Cammà, C., Di Marco, V., Giordano, C. et. al (2010). Visceral adiposity index is associated with histological findings and high viral load in patients with chronic hepatitis C due to genotype 1. Hepatology, 52 (5), 1543–1552. doi: 10.1002/hep.23859

Tvorogova, M. (2006). Metody opredelenia holesterina lipoproteinov niskoy plotnosti [Methods for determination of low density lipoprotein cholesterol]. Labor. medicina, 7, 29–37.

Kobsar, A. (2006). Prikladnaya matematicheskaya statiatika [Applied Mathematical Statistics]. Moscow: Physmatlit, 238.

Toth, P. P., Grabner, M., Punekar, R. S., Quimbo, R. A., Cziraky, M. J., Jacobson, T. A. (2014). Cardiovascular risk in patients achieving low-density lipoprotein cholesterol and particle targets. Atherosclerosis, 235 (2), 585–591. doi: 10.1016/j.atherosclerosis.2014.05.914

Published

2016-01-30

Issue

Section

Medical